Skip to content
Trial Eligibility
Menu

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

NCT05873634

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of breath, fluid retention, and fatigue. HeartShare aims to better classify heart failure into subtypes to help develop more personalized treatments for patients, with the hope that this will improve the lives of heart failure patients.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Heart Failure
  • Heart Failure With Preserved Ejection Fraction

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
30 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Northwestern University
Last updated on ClinicalTrials.gov
September 29, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California Davis · Sacramento, CA

Illinois · 1

  • Northwestern University · Chicago, IL

Minnesota · 1

  • Mayo Clinic · Rochester, MN

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.